v ::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::
ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

A DESCRIPTIVE STUDY ON HYPOMAGNESEMIA IN PATIENTS OF TYPE-II DIABETES MELLITUS

AUTHORS:

Dr. Adil Abdul Haye, Dr. Abdul Nafay

ABSTRACT:

Objective: To assess the frequency of hypomagnesemia in patients of type-II diabetes mellitus. Material and methods: This cross sectional study was conducted at Department of Medicine, Central Park Medical College Lahore from August 2019 to February 2020. Total 350 type-II diabetics, having age range 30-60 years, either male or female with duration of diabetes ≥ 3 years were selected. Hypomagnesemia was assessed in selected. Results: Total 350 type-II diabetics were selected and hypomagnesemia was asseseed. Mean age of the patients 45.34 ± 8.55 years with age range from 30-60 years and mean duration of diabetes was 6.54 ± 2.43 years. Out of 350 type-II diabetics, hypomagnesemia was found in 122 (35%) patients. Total 169 (48.29%) patients belonged to age group 30-45 years and 181 (51.71%) patients belonged to age group 46-60 years. Hypomagnesemia was found in 60 (35.50%) patients and 62 (34.25%) patients respectively in age group 30-45 years and age group 46-60 years. Statistically insignificant association of hypomagnesemia with age group was detected with p value 0.8232. Male diabetics were 197 (56.29%) and female diabetics were 153 (43.71%) and hypomagnesemia was noted in 72 (36.55%) male patients and in 50 (32.68%) female patients. Association of hypomagnesemia with gender was statistically insignificant with p value 0.4980 Conclusion: Results of present showed a higher percentage of hypomagnesemia in cases of type-II diabetes mellitus. A higher proportion of male gender was reported as compered to female gender and there is no association of hypomagnesemia with gender. Duration of diabetes, age and obesity were insignificantly associated with hypomagnesemia. Key words: Diabetes mellitus, endocrine, magnesium, enzyme activator

FULL TEXT

<
Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.